Xcout Intel
HeartBeat.bio
HeartBeat.bio is a biotechnology company founded in 2021 and located at the Vienna BioCenter in Austria, specializing in cardiac drug discovery. The company transforms cardiac drug recovery and development using innovative technologies originating from the Institute of Molecular Biotechnology (IMBA).
Subscribe to see HeartBeat.bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
HeartBeat.bio at a glance
HeartBeat.bio is a biotechnology company headquartered in Austria. Xcout tracks 12 named people at HeartBeat.bio, including Michael Krebs (Chief Executive Officer).
HeartBeat.bio leadership
- Michael KrebsChief Executive Officer
- Florian FuchsChief Technology Officer
- Pablo HofbauerChief Scientific Officer
- Stanko SkrticChief Development Officer
- Oliver SzolarCo-Founder and Deputy Chairman of the Supervisory Board
- Sasha MendjanCo-Founder and Member of the Scientific Advisory Board
6 more named people on record for HeartBeat.bio, with roles, board committees and tenure — see the full roster →
HeartBeat.bio competitors
A few of HeartBeat.bio's closest competitors — see the full list of competitors and alternatives →
River BioMedics is a Dutch biotechnology company headquartered in Enschede, Netherlands, founded in 2018. The company focuses on cardiovascular drug discovery by utilizing proprietary 3D human engineered heart tissue models to address unmet medical needs.
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Graph Therapeutics is a next-generation techbio company headquartered in Vienna, Austria. The company is involved in developing advanced therapeutic solutions.
Impact BioMedical Inc. is a pioneering biotechnology company incorporated in 2018 and based in Houston, Texas, dedicated to discovering, developing, and patenting innovative healthcare products, drug pipelines, and technology platforms.
Harmonic Discovery is a drug discovery company founded in 2021 and headquartered in New York City. The company leverages machine learning and precision pharmacology to develop therapeutics for complex diseases.
Get HeartBeat.bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on HeartBeat.bio in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access